Verfahren zur Inaktivierung von lipidumhüllten Viren

摘要

The invention relates to an extremly efficient inactivating process for lipid envelopped virus such as Herpes virus and retrovirus in - mainly pharmaceutical - biological or biotechnological products and in cell cultures, wherein a cyclical lipoleptide or a lipopeptide mixture or salts or esters thereof are added in certain concentrations. It appeared that lipopeptides have a surprisingly strong inactivating power on lipid envelopped virus and the additionnal advantage of very low vivo-toxicity, such that eliminating the inactivation agent in pharmaceutical products would no longer be necessary. The invention relates also to new antivirus lipopetides pertaining to the surfactine group.